|
CSNK1G3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.300200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.792080E-02 |
| Normal-vs-Stage2 |
6.791000E-01 |
| Normal-vs-Stage3 |
5.601200E-01 |
| Normal-vs-Stage4 |
2.237600E-01 |
| Stage1-vs-Stage2 |
4.261000E-01 |
| Stage1-vs-Stage3 |
4.903900E-02 |
| Stage1-vs-Stage4 |
9.620300E-02 |
| Stage2-vs-Stage3 |
4.499800E-01 |
| Stage2-vs-Stage4 |
1.896590E-01 |
| Stage3-vs-Stage4 |
3.224400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.711600E-02 |
| Normal-vs-AfricanAmerican |
1.819380E-01 |
| Normal-vs-Asian |
2.772800E-01 |
| Caucasian-vs-AfricanAmerican |
9.904800E-01 |
| Caucasian-vs-Asian |
1.619610E-01 |
| AfricanAmerican-vs-Asian |
1.120220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.481400E-03 |
| Normal-vs-Female |
2.451400E-01 |
| Male-vs-Female |
1.283760E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.274800E-01 |
| Normal-vs-Extreme_Weight |
8.979600E-03 |
| Normal-vs-Obese |
6.567000E-01 |
| Normal-vs-Extreme_Obese |
1.844060E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.339400E-01 |
| Normal_Weight-vs-Obese |
8.763800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.082800E-01 |
| Extreme_Weight-vs-Obese |
6.876400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.702800E-01 |
| Obese-vs-Extreme_Obese |
2.140200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.565600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.205600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.976100E-04 |
| Normal-vs-Age(81-100Yrs) |
2.058200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.517800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.998100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.181690E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.564800E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.820600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.109200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.417200E-03 |
| Normal-VS-Type2 PRCC |
3.994000E-01 |
| Normal-VS-KIRP CIMP |
5.861800E-02 |
| Normal-VS-Unclassified PRCC |
8.978600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.639600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.216410E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.307180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.935700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.005800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.619770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.103900E-02 |
| Normal-vs-N1 |
6.829700E-02 |
| Normal-vs-N2 |
5.503400E-01 |
| N0-vs-N1 |
8.803100E-03 |
| N0-vs-N2 |
1.868560E-01 |
| N1-vs-N2 |
7.660800E-01 |
|
|
